About Epigral
Epigral is a company based in Ahmedabad (India) founded in 1995 by Anand Patel, Jayanti Patel, Ramesh Patel, Natwarlal Patel, and Ashish Soparkar. Epigral has raised $11.5 million across 1 funding round from investors including International Finance Corporation. The company has 1,950 employees as of March 31, 2024. Epigral offers products and services including Chlor Alkali, Hydrogen Peroxide, Epichlorohydrin, CPVC, and Chloromethanes.
- Headquarter Ahmedabad, India
- Employees 1950 as on 31 Mar, 2024
- Founders Anand Patel, Jayanti Patel, Ramesh Patel, Natwarlal Patel, Ashish Soparkar
- Stage Public
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epigral Ltd
-
Annual Revenue
$294.16 M (USD)32.72as on Mar 31, 2024
-
Net Profit
$41.82 M (USD)82.62as on Mar 31, 2024
-
EBITDA
$80.26 M (USD)50.42as on Mar 31, 2024
-
Total Equity Funding
$11.5 M (USD)
in 1 rounds
-
Latest Funding Round
$11.5 M (USD), Series B
Jun 01, 2008
- Investors
-
Employee Count
1950
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Epigral
Epigral is a publicly listed company on the NSE with ticker symbol EPIGRAL in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Epigral
Epigral offers a comprehensive portfolio of products and services, including Chlor Alkali, Hydrogen Peroxide, Epichlorohydrin, CPVC, and Chloromethanes.
Produces caustic soda and chlorine for various industrial uses.
Used in paper, textiles, and chemicals as an eco-friendly agent.
Key component for epoxy resins and pharmaceuticals from renewable sources.
Provides resin and compounds for pipe manufacturing in construction.
Includes compounds for pharmaceuticals and refrigerant production.
People of Epigral
Unlock access to complete
Funding Insights of Epigral
Epigral has successfully raised a total of $11.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $11.5 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epigral
Epigral has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include International Finance Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
IFC is focused on private sector development in emerging markets.
|
Locked | Locked | Locked |
Investor details for Epigral
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epigral
Investment portfolio details for Epigral
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epigral
Detailed financials for Epigral
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epigral Comparisons
Peer comparison for Epigral
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epigral
Detailed competitors of Epigral
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epigral
Complete news archive for Epigral
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epigral
Epigral was founded in 1995 and raised its 1st funding round 13 years after it was founded.
Epigral is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Epigral is a funded company, having raised a total of $11.5M across 1 funding round to date.
As of Mar 31, 2024, the latest employee count at Epigral is 1,950.
Annual revenue of Epigral is $294.16M as on Mar 31, 2024.
Epigral Limited was founded in 1995 and is headquartered in Ahmedabad, India. Operations are focused on the production of chemicals utilized across multiple sectors within the Indian market, where a notable presence has been established. Emphasis is placed on safety protocols and quality standards through ongoing employee training and adherence to secure work practices. Various essential and specialty chemicals are supplied to support industrial applications.
Epigral offers Chlor Alkali, Hydrogen Peroxide, Epichlorohydrin, CPVC, and Chloromethanes.
Yes, Epigral is publicly traded on NSE under the ticker symbol EPIGRAL.
Epigral has 1 investor. Key investors include International Finance Corporation.
The ticker symbol of Epigral is EPIGRAL on NSE.